Jossinet J
Institut National de la Santé Et de la Recherche Médicale, INSERM Unité 281, Lyon, France.
Physiol Meas. 1998 Feb;19(1):61-75. doi: 10.1088/0967-3334/19/1/006.
A set of 120 impedivity spectra was collected in breast tissue immediately after excision from 64 patients undergoing breast surgery. The measurements were made at 12 discrete frequencies halving from 1 MHz to 488 Hz. The spectra were sorted into three groups of normal tissue, mammary gland, connective tissue and adipose tissue, and three groups of pathological tissue, mastopathy, fibroadenoma and carcinoma. Intergroup multiple comparisons of the components of impedivity and admittivity were systematically carried out at every measurement frequency. The low-frequency-limit resistivity, the fractional power and characteristic frequencies were calculated from the experimental data. No significant correlation between impedivity and admittivity and patient's age was observed, except for mastopathy. No significant difference between groups of normal tissue and benign pathology (mammary gland, mastopathy and fibroadenoma) was found. The group of carcinoma differed from all the other groups principally by the low-frequency-limit resistivity, the fractional power and the phase angle at frequency above 125 kHz. These results indicate that impedance spectroscopy is appropriate for the detection of breast cancer.
从64例接受乳房手术的患者切除的乳房组织中,立即收集了一组120个阻抗谱。测量在12个离散频率下进行,频率从1 MHz减半至488 Hz。这些谱被分为三组正常组织,即乳腺、结缔组织和脂肪组织,以及三组病理组织,即乳腺病、纤维腺瘤和癌。在每个测量频率下,系统地对阻抗和导纳的分量进行组间多重比较。根据实验数据计算低频极限电阻率、分数功率和特征频率。除乳腺病外,未观察到阻抗和导纳与患者年龄之间存在显著相关性。正常组织组与良性病变(乳腺、乳腺病和纤维腺瘤)组之间未发现显著差异。癌组与所有其他组的主要区别在于低频极限电阻率、分数功率以及频率高于125 kHz时的相角。这些结果表明,阻抗谱适用于乳腺癌的检测。